National Institute Of Cardiology
- Address
- Ul. Alpejska 42, 04-628 Warsaw, Poland
National Institute Of Cardiology
The National Institute of Cardiology is a distinguished cardiovascular research center with comprehensive expertise in complex congenital heart disease, acute coronary syndromes, and advanced heart failure management. The institution specializes in innovative therapeutic approaches for challenging cardiac conditions, conducting pivotal international trials that advance cardiovascular medicine and improve patient outcomes across diverse cardiac populations.
- Congenital heart disease including univentricular hearts and Fontan circulation management
- Acute myocardial infarction and acute coronary syndrome interventions
- Heart failure and pulmonary hypertension due to left heart disease
- Hypertrophic cardiomyopathy and coronary artery disease diagnostics
The center demonstrates particular strength in complex cardiovascular research, from pioneering work in functionally single ventricle patients post-Fontan operation to cutting-edge studies evaluating novel antiplatelet therapies and factor XIa inhibitors for secondary prevention after heart attacks. Their research portfolio includes advanced imaging techniques such as PET myocardial perfusion imaging, long-term safety studies of cardiac myosin inhibitors for cardiomyopathy, and therapeutic trials addressing lipid disorders in atherosclerotic cardiovascular disease, positioning them at the forefront of comprehensive cardiovascular care and innovation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Insel Gruppe AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in National Institute Of Cardiology
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study | Amgen Inc. | Phase III | Not Recruiting | May 2023 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2024-12-16 | 2024-12-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.